(Q40989142)

English

Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy

scientific article published on November 1995

Statements

Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversy (English)
1 November 1995
10 Suppl
2044-2052

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit